Home » Topics » BioWorld Science

BioWorld Science
RSS

Immatics and Celgene collaborate to develop novel adoptive cell therapies

Aug. 30, 2019

First patient enrolled in phase IIa study of sepranolone

Aug. 30, 2019

FDA accepts IND for clinical study of MR-301 for severe traumatic brain injury

Aug. 30, 2019

Pulmonary mucormycosis mouse model developed to test treatments

Aug. 30, 2019

Discovery of a targeted covalent CDK14 inhibitor with a TAIRE kinase-biased selectivity profile

Aug. 30, 2019

Novel Chemerin GPCR agonist OK-113 exhibits anti-inflammatory activity in DED mouse model

Aug. 30, 2019

OncoNano receives grant to support development of oncology product candidate ONM-500

Aug. 30, 2019

Neutrophils stick with dipeptidase in lung, liver

Aug. 30, 2019

Amyndas opens phase IIa study of AMY-101 in periodontal inflammation

Aug. 29, 2019

Phase III TULIP 2 trial of anifrolumab in SLE meets primary endpoint

Aug. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...